retatrutide dosage for weight loss VisualAbstract: reduces body by 17.5% in patients with obesity Watch This Video BEFORE Taking

The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase

Skip to main content Skip to main content AAN.com AAN Publications ABOUT About Neurology Today Editorial Board Subscription Services Reprints Rights and Permissions About the AAN Search Sign in Quick Search anywhere Enter search term Advanced Search Search SECTIONS Artificial Intelligence Ask the Ethicist At the Bench Best Advances Career Consult Disease Mechanisms Diversity For Your Patients In the Pipeline Viewpoint Neurotech Off the Clock Podcasts Policy and Practice Professionalism Society and Brain Then and Now Viewpoint Wellness TOPICS Behavioral Neurology/Dementia Cerebrovascular Disease Child Neurology COVID-19 Epilepsy Genetics Headache/Facial Pain Movement Disorders Multiple Sclerosis Neurocritical Care Neuroinfectious Disease Neuromuscular Neuro-oncology Neuro-ophthalmology/Neuro-otology Sleep Neurology Sports Neurology/Concussion MEETINGS Meetings We Cover Most Recent Coverage advertisement

By activating the receptors for both GLP-1 and GIP, tirzepatide helps your body in several ways: Enhances insulin secretion in response to meals Reduces glucose production by the liver Slows stomach emptying, leading to increased feelings of fullness These combined effects help regulate blood sugar and curb appetite, making it easier for patients to reduce food intake and achieve sustainable weight loss

Yes even though visible change won't appear for several weeks, taking a baseline photo on day one, before you've started, gives you an objective reference point for later comparison

J Endocrinol 1993

All GLP-1 RA labels mention to monitor for pancreatitis signs